H.C. Wainwright analyst Mitchell Kapoor maintained a Buy rating on Cartesian Therapeutics today and set a price target of $25.00. According to TipR......

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on LifeMD (LFMD), Corbus Pharmaceuticals (CRBP) and Car......

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on LifeMD (LFMD), Corbus Pharmaceuticals (CRBP) and Car......

Insiders have been trading these 5 stocks: (($JPM)), (($CVX)), (($MSTR)), (($MRNA)) and (($SNAP)). Here is a breakdown of their recent trades and t......

An update from TransCode Therapeutics ( ($RNAZ) ) is now available. On May 19, 2026, TransCode Therapeutics disclosed that it received a deficiency......

In a report released today, Alec Stranahan from Bank of America Securities maintained a Sell rating on Moderna, with a price target of $32.00. Acco......

Moderna ( ($MRNA) ) has fallen by -7.26%. Read on to learn why. Moderna’s share price slipped 7.26% over the past week, as investors weighed headli......

Moderna ($MRNA) announced an update on their ongoing clinical study. Moderna and Merck Advance Personalized Lung Cancer Vaccine Trial The Phase 3 s......

The SPDR S&P 500 ETF Trust ($SPY) rose 0.56% today, May 13, as a strong rebound in AI and semiconductor stocks outweighed hotter-than-expected infl......

Bernstein analyst Courtney Breen maintained a Hold rating on Moderna yesterday and set a price target of $45.00. The company’s shares closed yester......